Yizun Biopharmaceutical
Yizun Biotech offers cell therapy solutions, including universal technologies for treating solid tumors and allogeneic cells.
Launch date
Market cap
-
Enterprise valuation
$55—83m (Dealroom.co estimates Apr 2024.)
小营街道 Zhejiang (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Spinout | ||
N/A | Early VC | ||
* | N/A | Series A | |
CNY100m | Series A | ||
* | CNY100m | Series A | |
Total Funding | $27.5m |